Free provider profile
JEFFREY RICHMOND
NPI 1831414507
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2019-05-08.
1120 N LINCOLN ST STE 1601, DENVER, CO, 80203
720-432-9865
Single practice location
Enumerated 2010-04-06
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 7 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,038
Medicare patients
79
Part D drug cost
$346,330
Brand-name share
15.5%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Austedo (Deutetrabenazine) | 13 | $62,503 |
| Caplyta (Lumateperone Tosylate) | 16 | $26,639 |
| Lybalvi (Olanzapine/Samidorphan Malate) | 15 | $24,228 |
| Trintellix (Vortioxetine Hydrobromide) | 18 | $21,226 |
| Auvelity (Dextromethorphan Hbr/Bupropion) | 22 | $17,219 |
| Belsomra (Suvorexant) | 14 | $6,279 |
| Bupropion Xl (Bupropion Hcl) | 42 | $1,435 |
| Fluvoxamine Maleate (Fluvoxamine Maleate) | 11 | $1,376 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2023237 sessions · 13 patients · $225,812
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.